MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): A global overview

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue TOPIC T2, 2000, Pages 9-23

  Turner, P J ^a  

^a AstraZeneca   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASIA; BACTERIUM ISOLATE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; DRUG SURVEILLANCE PROGRAM; EUROPE; INTENSIVE CARE; INTERNATIONAL COOPERATION; MIDDLE EAST; MINIMUM INHIBITORY CONCENTRATION; NEUTROPENIA; NONHUMAN; STRAIN DIFFERENCE; WESTERN HEMISPHERE;

EID: 0033825147     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/46.suppl_2.9     Document Type: Article

References (31)

1. The crisis in antibiotic resistance
2. Resistance to antimicrobial drugs -A worldwide calamity
3. Hospital-acquired infections: Diseases with increasingly limited therapies
4. Report of the ASM task force on antibiotic resistance
5. The emergent needs for basic research, education and surveillance of antimicrobial resistance
6. A multicentre collaborative study of the antimicrobial susceptibility of community-acquired lower respiratory tract pathogens 1992-1993: The Alexander project
7. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE Phase 2
8. Meropenem: A microbiological overview
9. Antibacterial activity of meropenem against Gram-negative bacteria with a permeability defect and against staphylococci
10. Diffusion of β-lactam antibiotics through liposome membranes reconstituted from purified porins of the outer membranes of Pseudomonas aeruginosa
11. Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum β-lactamases
12. Interactions of meropenem with class I chromosomal β-lactamases
13. Activite in-vitro du meropeneme et de sept autres betalactamines vis-a-vis de Klebsiella pneumoniae et d'enterobacteries produisant des betalactamases a spectre elargi
14. Affinities of SM-7338 for penicillin-binding proteins and its release from these proteins in Staphylococcus aureus
15. Comparison of two carbapenems, SM-7338 and imipenem: Affinities for penicillin-binding proteins and its release from these proteins and morphological changes
16. The MYSTIC (meropenem yearly susceptibility test information collection) programme
17. MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from Europe: Comparison of antibiotic susceptibilities between countries and centre types
18. In-vitro activity of meropenem, imipenem, and penem HRE664 and ceftazidime against clinical isolates from West Germany
19. In vitro activity of meropenem against clinical isolates in a multicentre study in Italy
20. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated worldwide
21. Comparative in vitro activity of meropenem against selected pathogens from hospitalized patients in the Netherlands
22. Meropenem: Clinical response in relation to in vitro susceptibility
23. Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: Analysis of results from the SENTRY Antimicrobial Surveillance Program (1997)
24. Outer membrane proteins and susceptibility to carbapenems
25. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms
26. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients
27. Focused microbiologic surveillance by specific hospital unit as a sensitive means of defining antimicrobial resistance problems